
Janux, Vir stocks rally on positive data for Janux drug JANX007
Unity Software Stock Gets Relative Strength Rating Lift
US President-elect Donald Trump's promise to impose a 60% tariff on imports from China and a 10-20% tariff on all other imports has triggered a public debate about whether such policies are really so bad. After all, a tariff is a consumption tax, and most economists favour taxes on consumption over income taxes. But tariffs have significant drawbacks. Since they tax only imported products, they distort markets by shifting resources from more efficient foreign producers to less efficient domestic firms. This inefficiency comes at the expense of consumers, and like most consumption taxes, tariffs are regressive, placing a heavier burden on low-income households. Still, tariffs do have political appeal. Critics of globalisation in advanced economies have long argued that the efficiency gains from recent decades of trade liberalisation have been modest relative to the disruptions caused. While US consumers benefited from lower prices on imported goods, particularly from China, these widely dispersed gains were less salient than the concentrated pain of factory closures and job losses in regions exposed to import competition. The problem with such arguments is that they ignore the current macroeconomic context. Inflation over the last three years has increased consumer sensitivity to price changes. Voters today will be far more attuned to the inflationary pressures of tariffs than they were in the past. While proponents of new tariffs claim that China would bear the brunt of the financial burden, the evidence from the 2018-19 tariffs shows otherwise: US consumers bore most of the cost. Even if US prices remained unchanged, unintended consequences could follow. If broad-based tariffs led to a sharp depreciation of China's currency, the stronger dollar would make Chinese imports relatively cheaper. This may partly offset the higher prices caused by tariffs, but it would undermine the original goal of making US manufacturing more competitive. Meanwhile, the stronger dollar would hurt US exports, worsening the trade deficit. This suggests that the multiple goals currently advertised for tariffs -- reshoring manufacturing, reducing the trade deficit, generating revenue, lessening America's reliance on China, and forcing China into negotiations, all while minimising the impact on consumers -- often conflict with one another. This is because tariffs affect the US economy through prices. To boost US competitiveness or reduce the deficit, tariffs must raise import prices -- a politically toxic outcome today. Reducing America's reliance on China is also complex, given that Chinese-made intermediates are embedded in many goods exported to the US from third countries. Since 2018-19, China and several "bystander" countries have registered robust export growth despite tariffs. The proposed new tariffs might affect only direct Chinese exports to the US, not to other countries. The argument for tariffs as a revenue-generating mechanism is interesting and novel (in the sense that it has not been used for many centuries). But it does not hold up. Tariffs cannot possibly replace income taxes as a source of revenue: the scale of the income tax base is roughly an order of magnitude larger than the scale of imports. Still, tariffs could generate some government revenue, with China potentially bearing part of the cost. If used as a short-term negotiating tactic, they could apply some economic pressure on China. Strengthening the United States' negotiating leverage is the most compelling argument for tariffs. The 2018-19 tariffs led to the "phase one" agreement, a planned de-escalation in exchange for Chinese commitments to import more from the US and address concerns about intellectual property and technology transfers. But the 2018-19 tariffs were far from cost-free. They poisoned US-China relations, escalated tensions, pushed China into an alliance with Russia and Iran, and fueled anti-Asian sentiment domestically. They eroded America's relationships with allies who were not consulted and who found themselves also targeted by specific tariffs. And when all was said and done, the phase one deal's full impact was never realised. The disruption to trade from the pandemic meant that China fell far short of its commitments to purchase goods from the US. Today's tariff proposals risk repeating history, only on a grander scale. The incoming administration will face a wary, inflation-sensitive public and a Chinese regime that is well prepared to pursue large-scale retaliation. Whether tariffs become a negotiating tool or a source of greater economic disruption depends on how the administration balances competing objectives. Reason and strategic foresight will be crucial. ©2024 Project Syndicate Pinelopi Koujianou Goldberg, a former World Bank Group chief economist and editor-in-chief of the American Economic Review, is Professor of Economics at Yale University.
NoneVornado Realty Trust stock outperforms competitors despite losses on the day
Paccar Inc. stock rises Monday, outperforms marketDaniel Jones is free to sign with any NFL team after clearing waivers on Monday, which also means the team that signs the former New York Giants quarterback won't be on the hook for the nearly $12 million that was remaining on his contract this year or his $23 million injury guarantee. Jones was released at his request by the Giants on Saturday after the former first-round pick was benched last week. He reportedly wants to join a contender, and there are expected to be multiple teams interested. The two teams reported to have the most initial interest in Jones are also being offered as the most likely to sign him by one sportsbook. The Baltimore Ravens currently have journeyman backup Josh Johnson behind starting quarterback Lamar Jackson. Jones would potentially provide a third option, and one whose mobility could make him an intriguing fit in offensive coordinator Todd Monken's system The Ravens were installed as the 2/1 favorites to land Jones ahead of the Minnesota Vikings (5/2), who have veterans Nick Mullens and Brett Rypien behind starter Sam Darnold. They would likely view Jones as an upgrade. "I really can't get into too much about any short-term or long-term," Vikings coach Kevin O'Connell said Monday when asked about Jones, per ESPN's Adam Schefter. "I can just say that I've been a big fan of Daniel's for a long time and I hope wherever his next step takes him, it's a good opportunity for him." The Las Vegas Raiders (5/1) don't fall into the category of contenders after falling to 2-9 amid a seven-game losing streak. However, they could provide the most immediate opportunity to play with Gardner Minshew suffering a season-ending broken collarbone on Sunday that is expected to end his season. Second-year quarterback Aidan O'Connell is close to returning from a thumb injury, but coach Antonio Pierce acknowledged after Sunday's game that, "We're going to need somebody, right?" If O'Connell isn't ready to face the Kansas City Chiefs on Black Friday, Desmond Ridder is expected to get the start. The Dallas Cowboys (7/1) would fall into a similar category, with Dak Prescott out for the season following hamstring surgery and being replaced by Cooper Rush. Another intriguing possibility lies with Detroit, where the 10-1 Lions' offense is rolling with Jared Goff at the helm. However, should he go down to injury the only other quarterback on the roster is rookie Hendon Hooker. That has contributed to the Lions having 7/1 odds to sign Jones. DANIEL JONES NEXT TEAM ODDS* Baltimore Ravens (2/1) Minnesota Vikings (5/2) Las Vegas Raiders (5/1) Dallas Cowboys (7/1) Detroit Lions (7/1) Miami Dolphins (7/1) San Francisco 49ers (8/1) Carolina Panthers (10/1) Seattle Seahawks (16/1) Indianapolis Colts (20/1) New England Patriots (25/1) New Orleans Saints (25/1) New York Jets (25/1) Tennessee Titans (25/1) Atlanta Falcons (28/1) Arizona Cardinals (33/1) Chicago Bears (33/1) Cleveland Browns (33/1) Denver Broncos (33/1) Jacksonville Jaguars (40/1) Los Angeles Chargers (50/1) Los Angeles Rams (50/1) Pittsburgh Steelers (50/1) Tampa Bay Buccaneers (50/1) Washington Commanders (50/1) Cincinnati Bengals (66/1) Green Bay Packers (66/1) Houston Texans (66/1) Philadelphia Eagles (66/1) Buffalo Bills (75/1) Kansas City Chiefs (75/1) Any CFL Team (80/1) Any XFL Team (80/1) *Odds provided by SportsBetting.ag are for entertainment purposes only. --Field Level Media
Qatar tribune Agencies Gaza The Israeli military has continued “its intensive land, air and sea aggression on northern Gaza for 60 days” that also wounded 10,000 others, Gaza’s Media Office said. A statement by the office on Telegram said 2,400 of the 3,700 people who were killed or missing were “buried” under the rubble. During the offensive, the Israeli forces also detained 1,750 people, the office added. “The occupation also targeted and prevented the work of civil defence crews in the governorate, in addition to its destruction of vital sectors,” most notably the health sector and water networks, it said. The statement said the condition of the sanitation facilities, infrastructure and road networks exacerbated the humanitarian crisis in northern Gaza, declaring the region “disaster-stricken in every sense of the word”. The Media Office also said a decision by the UN refugee agency for Palestinians (UNRWA) to halt the delivery of much-needed aid to the hunger-stricken, besieged territory is “shocking and surprising”. In a statement, the office blamed Israel for the “dangerous ramifications” of the move and called on UNRWA to resume the delivery of aid via other border crossings. Earlier, UNRWA said its decision to stop delivering aid via the Karem Abu Salem (Kerem Shalom to Israelis) crossing was due to security concerns. “We urge to uphold its humanitarian responsibilities and retract the decision that is going to threaten the lives of more than two million people, especially women and children,” it said. UNRWA has said humanitarian aid reaching Gaza for the past year of war has been “nowhere near enough” for its 2.2 million population. “While attacks continue, people, including children, are facing hunger, living in shelters and tents, and relying on humanitarian aid,” UNRWA said on X. According to its count, only 65 aid trucks per day had been able to enter Gaza this past month, compared with a pre-war average of 500. International aid organisations have repeatedly raised alarm over the deteriorating conditions in Gaza, warning that civilians are on the brink of famine. They have said aid shipments reaching the enclave are now at their lowest since the start of the war. UNRWA chief Philippe Lazzarini has said the agency “remains the backbone of humanitarian response” in Gaza. In an address in Cairo, he called for the use of “a robust international legal and political framework” to ensure the continuation of humanitarian aid to Gaza. “Without this, humanitarians, however selfless and courageous, cannot stay and deliver,” he added. The UN agency recently announced it was stopping aid deliveries to Gaza from the key Karem Abu Salem (Kerem Shalom) crossing between Israel and Gaza due to the deteriorating security situation. Meanwhile, the Israeli military on Monday declared another of the hostages held by Hamas in the Gaza Strip to be dead. The hostage in question is a 21-year-old Israeli-American soldier born in New York, the Israel Defense Forces (IDF) wrote on social media platform X. He was killed during the Hamas-led October 7 attacks on Israel and his body has been held in the Gaza Strip ever since, according to the IDF, citing intelligence. The Hostages and Missing Families Forum, a group that represents the family members of hostages still held in Gaza as well as the Israeli communities attacked on October 7, said that the soldier, a tank commander, had been abducted along with other troops that day. Hamas and other groups crossed the border from the Gaza Strip into Israel on October 7 last year, killing around 1,200 people and abducting more than 250 others. Israel responded by pounding Gaza with airstrikes and launching a ground offensive into the Palestinian territory. At least 44,000 people have been killed in Gaza since the war began, according to the Hamas-controlled health authority. Many of the 100 hostages still unaccounted for are no longer believed to be alive. They include holders of dual nationality, including US citizens. Meanwhile, the armed wing of Hamas, the Qassam Brigades, said its fighters have targeted “enemy positions” in the kibbutzim of Nirim and Ein HaShlosha in southern Israel with several rockets.At least 44,466 people have been killed and 105,358 wounded in Israeli attacks on Gaza since October 7, 2023, the enclave’s Health Ministry said, on Monday. Of those, 37 Palestinians were killed and 108 wounded in the latest 24-hour reporting period, the ministry added. (Agencies) Copy 03/12/2024 10Published 4:50 pm Monday, November 25, 2024 By Data Skrive There are four games featuring a ranked team on the Tuesday college basketball schedule, including the Arizona State Sun Devils versus the Kentucky Wildcats. Watch women’s college basketball, other live sports and more on Fubo. What is Fubo? Fubo is a streaming service that gives you access to your favorite live sports and shows on demand. Use our link to sign up for a free trial. Catch tons of live women’s college basketball , plus original programming, with ESPN+ or the Disney Bundle.
NEW YORK , Nov. 22, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of all purchasers of securities of Xerox Holdings Corporation (NASDAQ: XRX) between January 25, 2024 and October 28, 2024 . Xerox describes itself as a "company that offers workplace technology that integrates hardware, services, and software for enterprises in the Americas, and internationally." Javascript is required for you to be able to read premium content. Please enable it in your browser settings.
Eminem’s mother Debbie Nelson, whose rocky relationship fueled the rapper’s lyrics, dies at age 69The House of Representatives at the plenary on Thursday rejected a bill, seeking to amend the 1999 constitution to provide for a single term of six years for the Offices of the President, State Governors and Local Government Areas Chairmen. The bill which was sponsored by Rep Ikenga Ugochinyere (PDP-Imo) and 33 other lawmakers also seeks zonal rotation of presidential and governorship seats, as well as holding of the elections in one day. The proposed legislation seeks to alter Sections 76, 116, 132, 136, and some others of the 1999 Constitution (as amended). According to the general principles of the bill, “these amendments was to ensure inclusive governance and to curb wastages occasioned by four year periodic elections. “The bill among others seeks amendment of Section 132 of the Principal Act by inserting a new subsection (2), deleting the extant subsection (4) and renumbering the entire section accordingly to provide that an election to the office of President of the Federal Republic of Nigeria shall be rotated between the North and the South regions of the country every six years. “Other amendments include, Section 76 of the Principal Act is altered by inserting a new subsection (3) as follows; (3) For the Purposes of Section (1) of this section, all elections into the offices of President, Governors, National Assembly and State Houses of Assembly shall hold simultaneously on the same date to be determined by the Independent National Electoral Commission in consultation with the National Assembly and in accordance with the Electoral Act. “Section 116 of the Principal Act is amended by inserting a new a subsection (3) as follows; < For the purposes of subsection (1) of this section, all elections into the offices of President, Governors, National Assembly, State Houses of Assembly and Local Government Councils shall be held simultaneously on the same date to be determined by the Independent National Electoral Commission (INEC) in consultation with the National Assembly and in accordance with the Electoral Act. “Section 132 of the Principal Act is amended by inserting a new é subsection (2), deleting the extant subsection (4) and renumbering the entire section accordingly: An election to the office of President of the Federal Republic of Nigeria shall be rotated between the North and the South regions of the Country every six years. Provided that where it is the turn of the North or South to present a candidate for election into the office of President, it shall be rotated among the three geo-political zones that constitutes the regions. The extant subsection (2) becomes subsection (3) The extant subsection (3) becomes subsection (4) The extant subsection (4) is hereby deleted The extant subsection (5) remains subsection (5). “Section 136 of the Principal Act is amended by deleting the a extant subsections 1 & 2 and replacing them with new subsections I, 2 and 3 as follows: If a person duly elected as President dies before taking and subscribing the Oath of Allegiance and oath of office. or is for any reason whatsoever unable to be sworn in, the person elected with him as First Vice President shall be sworn in as President and he shall appoint a new First Vice President with the approval by a simple majority of the National Assembly at a joint sitting. “A person who was sworn in as Governor to complete the term for which another person was elected as Governor shall not be elected to such office for another term. The Principal Act is altered by inserting a new Section 188 immediately after the extant 187 and immediately before the extant 188 and renumbering accordingly as follows; 188(1) Notwithstanding any other provision, the Governor shall present a mid-term account of stewardship performance report to the State House of Assembly at the end of the third year of the six-year term. The State House of Assembly shall determine by a resolution supported by not less than two-third majority of members whether the Governor bas by the account of stewardship report justified his continuous stay in office. Where, upon the consideration of the mid-term report under subsection (1) of this section, the State House of Assembly is not satisfied with the performance of the Governor for the period he has been in office, the State House of Assembly shall pass a vote of no confidence on the Governor. The State House of Assembly shall immediately commence the process for the impeachment of the Governor from office.” The Bill was put to a voice vote by the Speaker who presided over the plenary session and the nays had it.
None
MAHWAH, N.J.--(BUSINESS WIRE)--Nov 25, 2024-- KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will participate in Piper Sandler’s 36 th Annual Healthcare Conference on December 5, 2024. KORU Medical's management is scheduled to present at Piper Sandler’s 36 th Annual Healthcare Conference on December 5, 2024, at 11:00 am ET. Interested parties can access the live and archived webcast on the News/Events page of the Investors section of KORU Medical’s website at www.korumedical.com . About KORU Medical Systems KORU Medical develops, manufactures, and commercializes innovative and patient-centric large volume subcutaneous infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System (“the FREEDOM System”) currently includes the FREEDOM60 ® and FreedomEdge ® Syringe Infusion Drivers, Precision Flow Rate TubingTM and HIgH-Flo Subcutaneous Safety Needle SetsTM. The Freedom System, which received its first FDA clearance in 1994, is used for self-administration in the home by the patient and/or delivery in an ambulatory infusion center by a healthcare professional. Through its Novel Therapies business, KORU Medical provides products for use by biopharmaceutical companies in feasibility/clinical trials during the drug development process and, as needed, is capable of customizing the Freedom System for clinical and commercial use across multiple drug categories. For more information, please visit www.korumedical.com . View source version on businesswire.com : https://www.businesswire.com/news/home/20241125412289/en/ CONTACT: Investor Contact: Greg Chodaczek 347-620-7010 investor@korumedical.com KEYWORD: NEW JERSEY UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: MEDICAL DEVICES HEALTH CLINICAL TRIALS HEALTH TECHNOLOGY MEDICAL SUPPLIES SOURCE: KORU Medical Systems Copyright Business Wire 2024. PUB: 11/25/2024 04:05 PM/DISC: 11/25/2024 04:05 PM http://www.businesswire.com/news/home/20241125412289/enDaniel Jones is free to sign with any NFL team after clearing waivers on Monday, which also means the team that signs the former New York Giants quarterback won't be on the hook for the nearly $12 million that was remaining on his contract this year or his $23 million injury guarantee. Jones was released at his request by the Giants on Saturday after the former first-round pick was benched last week. He reportedly wants to join a contender, and there are expected to be multiple teams interested. The two teams reported to have the most initial interest in Jones are also being offered as the most likely to sign him by one sportsbook. The Baltimore Ravens currently have journeyman backup Josh Johnson behind starting quarterback Lamar Jackson. Jones would potentially provide a third option, and one whose mobility could make him an intriguing fit in offensive coordinator Todd Monken's system The Ravens were installed as the 2/1 favorites to land Jones ahead of the Minnesota Vikings (5/2), who have veterans Nick Mullens and Brett Rypien behind starter Sam Darnold. They would likely view Jones as an upgrade. "I really can't get into too much about any short-term or long-term," Vikings coach Kevin O'Connell said Monday when asked about Jones, per ESPN's Adam Schefter. "I can just say that I've been a big fan of Daniel's for a long time and I hope wherever his next step takes him, it's a good opportunity for him." The Las Vegas Raiders (5/1) don't fall into the category of contenders after falling to 2-9 amid a seven-game losing streak. However, they could provide the most immediate opportunity to play with Gardner Minshew suffering a season-ending broken collarbone on Sunday that is expected to end his season. Second-year quarterback Aidan O'Connell is close to returning from a thumb injury, but coach Antonio Pierce acknowledged after Sunday's game that, "We're going to need somebody, right?" If O'Connell isn't ready to face the Kansas City Chiefs on Black Friday, Desmond Ridder is expected to get the start. The Dallas Cowboys (7/1) would fall into a similar category, with Dak Prescott out for the season following hamstring surgery and being replaced by Cooper Rush. Another intriguing possibility lies with Detroit, where the 10-1 Lions' offense is rolling with Jared Goff at the helm. However, should he go down to injury the only other quarterback on the roster is rookie Hendon Hooker. That has contributed to the Lions having 7/1 odds to sign Jones. DANIEL JONES NEXT TEAM ODDS* Baltimore Ravens (2/1) Minnesota Vikings (5/2) Las Vegas Raiders (5/1) Dallas Cowboys (7/1) Detroit Lions (7/1) Miami Dolphins (7/1) San Francisco 49ers (8/1) Carolina Panthers (10/1) Seattle Seahawks (16/1) Indianapolis Colts (20/1) New England Patriots (25/1) New Orleans Saints (25/1) New York Jets (25/1) Tennessee Titans (25/1) Atlanta Falcons (28/1) Arizona Cardinals (33/1) Chicago Bears (33/1) Cleveland Browns (33/1) Denver Broncos (33/1) Jacksonville Jaguars (40/1) Los Angeles Chargers (50/1) Los Angeles Rams (50/1) Pittsburgh Steelers (50/1) Tampa Bay Buccaneers (50/1) Washington Commanders (50/1) Cincinnati Bengals (66/1) Green Bay Packers (66/1) Houston Texans (66/1) Philadelphia Eagles (66/1) Buffalo Bills (75/1) Kansas City Chiefs (75/1) Any CFL Team (80/1) Any XFL Team (80/1) *Odds provided by SportsBetting.ag are for entertainment purposes only. --Field Level Media Get any of our free daily email newsletters — news headlines, opinion, e-edition, obituaries and more.
Broncos waive TE Greg Dulcich, 2022 third-round pick, after eight straight inactive weeksF-35C stealth fighter makes combat debut with US Marine Corps air strikes
ORRVILLE, Ohio , Dec. 17, 2024 /PRNewswire/ -- The J. M. Smucker Company (the "Company") (NYSE: SJM) today announced the pricing terms for its previously announced cash tender offers (each, an "Offer" and collectively, the "Offers") to purchase up to $300 million aggregate purchase price, not including accrued and unpaid interest (the "Offer Cap"), of the Company's validly tendered (and not validly withdrawn) notes set forth below (the "Notes") using a "waterfall" methodology under which the Company will accept the Notes in order of their respective acceptance priority levels noted in the table below (the "Acceptance Priority Levels"). The Offers are being made pursuant to an Offer to Purchase, dated December 3, 2024 (the "Offer to Purchase"), which sets forth a description of the terms of the Offers. As of 10:00 a.m. New York City time, on December 17, 2024 (the "Price Determination Time"), the Company expects to accept for purchase pursuant to the Offers the full amount of the 2.750% Senior Notes due 2041 (which have an Acceptance Priority Level of 1), the full amount of the 3.550% Senior Notes due 2050 (which have an Acceptance Priority Level of 2) and a portion of the 2.125% Senior Notes due 2032 (which have an Acceptance Priority Level of 3) validly tendered and not validly withdrawn at or prior to the Early Tender Time (as defined below) on a prorated basis as described in the Offer to Purchase, using a proration factor of approximately 69.9%, so that the aggregate purchase price does not exceed the Offer Cap. The 4.375% Senior Notes due 2045 (which have an Acceptance Priority Level of 4) and the 5.900% Senior Notes due 2028 (which have an Acceptance Priority Level of 5) will not be accepted for purchase. The "Total Consideration" to be paid for the Notes validly tendered (and not validly withdrawn) at or prior to 5:00 p.m. , New York City time, on December 16, 2024 (the "Early Tender Time") and accepted for purchase pursuant to the Offers, includes an early tender premium of $30 per $1,000 principal amount of Notes so tendered and accepted for purchase (the "Early Tender Premium"), which will not constitute an additional or increased payment. In addition to the applicable Total Consideration, holders who validly tender and do not validly withdraw their Notes, and whose Notes are accepted for purchase in the Offers will also be paid any applicable accrued and unpaid interest up to, but excluding, December 19, 2024 (the "Early Settlement Date"). The Total Consideration has been determined in the manner described in the Offer to Purchase by reference to a fixed spread for each of the Notes over the applicable yield to maturity of the applicable U.S. Treasury Security (the "Reference Treasury Security"), determined at the Price Determination Time as specified in the table below and on the cover page of the Offer to Purchase in the column entitled "Reference U.S. Treasury Security." The table below includes only the Notes validly tendered (and not validly withdrawn) at or prior to the Early Tender Time that the Company expects to accept for purchase pursuant to the Offers. Acceptance Priority Level (1) Title of Security CUSIP Number Outstanding Principal Amount Reference U.S. Treasury Security (2) Bloomberg Reference Page Reference Yield Fixed Spread (bps) Total Consideration (3) 1 2.750% Senior Notes due 2041 832696AV0 $300,000,000 4.625% UST due 11/15/2044 FIT 1 4.666 % +85 $700.18 2 3.550% Senior Notes due 2050 832696AT5 $300,000,000 4.250% UST due 8/15/2054 FIT 1 4.596 % +95 $730.52 3 2.125% Senior Notes due 2032 832696AU2 $500,000,000 4.250% UST due 11/15/2034 FIT 1 4.391 % +50 $833.04 All conditions of the Offers were deemed satisfied by the Company, or timely waived by the Company. Accordingly, the Company expects to accept for purchase, and pay for, $300 million aggregate purchase price of Notes validly tendered (and not validly withdrawn) on the Early Settlement Date. Although the Offers are scheduled to expire at 5:00 p.m. , New York City time, on January 2, 2025, unless extended or terminated, because the aggregate purchase price of Notes validly tendered (and not validly withdrawn) prior to or at the Early Tender Time exceeded the Offer Cap, there will be no Final Settlement Date (as defined in the Offer to Purchase), and no Notes tendered after the Early Tender Time will be accepted for purchase. Notes tendered and not purchased on December 19, 2024 (the "Early Settlement Date") will be returned to holders promptly after the Early Settlement Date. This press release is neither an offer to purchase nor a solicitation of an offer to sell securities. No offer, solicitation, purchase or sale will be made in any jurisdiction in which such offer, solicitation, or sale would be unlawful. The Offers are being made solely pursuant to the terms and conditions set forth in the Offer to Purchase. Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC are serving as Dealer Managers for the Offers (each, a "Dealer Manager" and together, the "Dealer Managers"). Questions regarding the Offers may be directed to Goldman Sachs at (800) 828-3182 (toll free) or (212) 357-1452 (collect) or to J.P. Morgan at (866) 834-4666 (toll free) or (212) 834-3554 (collect). Requests for the Offer to Purchase or the documents incorporated by reference therein may be directed to D.F. King & Co., Inc., which is acting as the Tender Agent and Information Agent for the Offers, at SJM@dfking.com or the following telephone numbers: banks and brokers at (212) 269-5550; all others toll free at (866) 620-2535. The J. M. Smucker Company Forward-Looking Statements This press release ("Release") includes certain forward-looking statements within the meaning of federal securities laws. The forward-looking statements may include statements concerning our current expectations, estimates, assumptions and beliefs concerning future events, conditions, plans and strategies that are not historical fact. Any statement that is not historical in nature is a forward-looking statement and may be identified by the use of words and phrases such as "expect," "anticipate," "believe," "intend," "will," "plan," "strive" and similar phrases. Federal securities laws provide a safe harbor for forward-looking statements to encourage companies to provide prospective information. We are providing this cautionary statement in connection with the safe harbor provisions. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date made, when evaluating the information presented in this Release, as such statements are by nature subject to risks, uncertainties and other factors, many of which are outside of our control and could cause actual results to differ materially from such statements and from our historical results and experience. These risks and uncertainties include, but are not limited to, the following: our ability to successfully integrate Hostess Brands' operations and employees and to implement plans and achieve financial forecasts with respect to the Hostess Brands' business; our ability to realize the anticipated benefits, including synergies and cost savings, related to the Hostess Brands acquisition, including the possibility that the expected benefits will not be realized or will not be realized within the expected time period; disruption from the acquisition of Hostess Brands by diverting the attention of our management and making it more difficult to maintain business and operational relationships; the negative effects of the acquisition of Hostess Brands on the market price of our common shares; the amount of the costs, fees, expenses, and charges and the risk of litigation related to the acquisition of Hostess Brands; the effect of the acquisition of Hostess Brands on our business relationships, operating results, ability to hire and retain key talent, and business generally; disruptions or inefficiencies in our operations or supply chain, including any impact caused by product recalls, political instability, terrorism, geopolitical conflicts (including the ongoing conflicts between Russia and Ukraine and Israel and Hamas), extreme weather conditions, natural disasters, pandemics, work stoppages or labor shortages (including potential strikes along the U.S. East and Gulf coast ports and potential impacts related to the duration of a recent strike at our Buffalo, New York manufacturing facility), or other calamities; risks related to the availability of, and cost inflation in, supply chain inputs, including labor, raw materials, commodities, packaging, and transportation; the impact of food security concerns involving either our products or our competitors' products, including changes in consumer preference, consumer litigation, actions by the U.S. Food and Drug Administration or other agencies, and product recalls; risks associated with derivative and purchasing strategies we employ to manage commodity pricing and interest rate risks; the availability of reliable transportation on acceptable terms; our ability to achieve cost savings related to our restructuring and cost management programs in the amounts and within the time frames currently anticipated; our ability to generate sufficient cash flow to continue operating under our capital deployment model, including capital expenditures, debt repayment to meet our deleveraging objectives, dividend payments, and share repurchases; a change in outlook or downgrade in our public credit ratings by a rating agency below investment grade; our ability to implement and realize the full benefit of price changes, and the impact of the timing of the price changes to profits and cash flow in a particular period; the success and cost of marketing and sales programs and strategies intended to promote growth in our business, including product innovation; general competitive activity in the market, including competitors' pricing practices and promotional spending levels; our ability to attract and retain key talent; the concentration of certain of our businesses with key customers and suppliers, including primary or single-source suppliers of certain key raw materials and finished goods, and our ability to manage and maintain key relationships; impairments in the carrying value of goodwill, other intangible assets, or other long-lived assets or changes in the useful lives of other intangible assets or other long-lived assets; the impact of new or changes to existing governmental laws and regulations and their application; the outcome of tax examinations, changes in tax laws, and other tax matters; a disruption, failure, or security breach of our or our suppliers' information technology systems, including, but not limited to, ransomware attacks; foreign currency exchange rate and interest rate fluctuations; and risks related to other factors described under "Risk Factors" in other reports and statements we have filed with the SEC. We do not undertake any obligation to update or revise these forward-looking statements to reflect new events or circumstances. About The J. M. Smucker Company At The J.M. Smucker Co., it is our privilege to make food people and pets love by offering a diverse family of brands available across North America . We are proud to lead in the coffee, peanut butter, fruit spreads, frozen handheld, sweet baked goods, dog snacks, and cat food categories by offering brands consumers trust for themselves and their families each day, including Folgers ® , Dunkin' ® , Café Bustelo ® , Jif ® , Uncrustables ® , Smucker's ® , Hostess ® , Milk-Bone ® , and Meow Mix ® . Through our unwavering commitment to producing quality products, operating responsibly and ethically, and delivering on our Purpose, we will continue to grow our business while making a positive impact on society. For more information, please visit jmsmucker.com . The J. M. Smucker Company is the owner of all trademarks referenced herein, except for Dunkin' ® , which is a trademark of DD IP Holder LLC. The Dunkin'® brand is licensed to The J. M. Smucker Company for packaged coffee products sold in retail channels, such as grocery stores, mass merchandisers, club stores, e-commerce and drug stores, as well as in certain away from home channels. This information does not pertain to products for sale in Dunkin' ® restaurants. View original content to download multimedia: https://www.prnewswire.com/news-releases/the-j-m-smucker-company-announces-pricing-for-cash-tender-offers-302334213.html SOURCE The J.M. Smucker Co.Building Large-Scale Machine Learning/AI Systems with Niloy GuptaAFTER much speculation the first Riyadh Season card of 2025 is now official and it promises to be a very special night of boxing. The announcement was made tonight by Turki Alalshikh on social media platform X with promoters Frank Warren and Eddie Hearn following suit. On February 22 in Riyadh, Saudi Arabia the undisputed light heavyweight title will once again be on the line when champion Artur Beterbiev, 21-0 (20 KOs), faces Dmitry Bivol, 23-1 (12 KOs), in a rematch four months on from their first fight. That October night Beterbiev squeaked past Bivol by split decision to take home all four world titles. The result was a contentious one, however, and now the top two at 175lbs will run it back. IBF heavyweight champion Daniel Dubois, 22-2 (21 KOs), makes the second defence of his belt against former WBO titlist Joseph Parker, 35-3 (23 KOs). The Brit comes into the bout having knocked out former divisional boss Anthony Joshua but faces a rejuvenated Parker who has scored wins against Deontay Wilder and Zhilei Zhang. Shakur Stevenson, 22-0 (10 KOs) makes his first appearance on a Riyadh Season card when Matchroom’s latest marquee signing defends his WBC lightweight title against the up and coming Floyd Schofield, 18-0 (12 KOs). Stevenson had hoped to face Golden Boy Promotions’ lightweight star William Zepeda but the Mexican withdrew because of injury giving Schofield the biggest fight of his career. Britain could have another world champion by the end of the night if Hamzah Sheeraz, 21-0 (17 KOs) can dethrone WBC middleweight champion Carlos Adames, 24-1 (18 KOs). Promoter Frank Warren confirmed weeks ago that his middleweight star would fight for a world title next year with many believing it would come against the current 160lbs number one Zhanibek Alimkhanuly. That fight was put to one side, however, when Sheeraz withdrew from his mandatory position from the WBO to focus instead on the green and gold belt. The lively super welterweight scene adds another intriguing fight to its list on February 22 when Vergil Ortiz Jr, 22-0 (21 KOs), does battle with Israil Madrimov, 10-1-1 (7 KOs) for the WBC’s Interim 154lb strap. It remains to be seen, though, if Madrimov will fight on December 21 in Riyadh against Serhii Bohachuk. Their scheduled bout comes nine weeks before facing Ortiz Jr. The latter was linked to a fight against Jaron Ennis but with no agreement made the unbeaten 26-year-old gets to pit his wits against the former WBA champion Madrimov who lost narrowly to Terence Crawford in August. Another heavyweight battles lands in Riyadh on the same night when Zhilei Zhang, 27-2-1 (22 KOs), and Agit Kabayel, 25-0 (17 KOs), lock horns for the WBC Interim heavyweight belt. Zhang returned to winning way beating Wilder last time out while Kabayel has made the most of his slots on Riyadh Season cards impressing against Arslanbek Makhmudov and Frank Sanchez. Rounding off the announcement is a fight which could easily top a televised card in the UK. Joshua Buatsi, 19-0 (13 KOs), puts his world title aspirations on the line when he defends his WBO Interim belt against Callum Smith, 30-2 (22 KOs). Buatsi looked at his spiteful best beating Willy Hutchinson in September while Smith, who lost to Beterbiev in January, continues to pursue his ambitions of becoming a two-weight world champion. The hard-hitting Liverpudlian dusted off the cobwebs after a 10 month layoff by stopping Carlos Galvan in five rounds on Saturday night.KORU Medical Systems to Participate in Piper Sandler’s 36th Annual Healthcare Conference